Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1

Endocrine Journal

Volumn 56, Issue 7, 2009, Pages 887-895

  Sakurai, Akihiro ^a,b   Murakami, Akiko ^c   Sano, Kenji ^a   Uchino, Shinya ^c   Fukushima, Yoshimitsu ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hokushin General Hospital   (Japan)

^c Noguchi Thyroid Clin/Hosp Found   (Japan)

Author keywords

Loss of heterozygosity; p27; Tumor suppressor; Two hit theory

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; METHIONINE;

ADULT; ALLELE; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE AMPLIFICATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PROTEIN EXPRESSION; SOMATIC MUTATION; TUMOR CELL;

CARCINOID TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; GERM-LINE MUTATION; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEUROENDOCRINE TUMORS; PROTO-ONCOGENE PROTEINS; RETROPERITONEAL NEOPLASMS;

EID: 70350680929     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-126     Document Type: Article

References (39)

1. Marx SJ, Stratakis CA (2005) Multiple endocrine neoplasia - Introduction. J Intern Med 257: 2-5.
2. Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29: 22-32.
3. Balogh K, Rácz K, Patócs A, Hunyady L (2007) Menin and its interacting proteins: elucidation of menin function. Trends Endocrinol Metab 17: 357-364. (Pubitemid 44584731)
4. Milne TA Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, Hua X, Roeder RG, Meyerson M, Hess JL (2005) Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci USA 102: 749-754. (Pubitemid 40282737)
5. INK4c. Proc Natl Acad Sci USA 2005 102 14659-14664.
6. Schnepp RW, Chen YX, Wang H, Cash T, Silva A, Diehl JA, Brown E, Hua X (2006) Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells. Cancer Res 66: 5707-5715. (Pubitemid 43927123)
7. Fontanière S, Casse H, Bertolino P, Zhang CX (2006) Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice. Fam Cancer 5: 49-54. (Pubitemid 43384319)
8. Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103: 15558-15563. (Pubitemid 44625631)
9. Fritz A, Walch A, Piotrowska K, Rosemann M, Schäffer E, Weber K, Timper A, Wildner G, Graw J, Höfler H, Atkinson MJ (2002) Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. Cancer Res 62: 3048-3051. (Pubitemid 34602393)
10. Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92: 3321-3325. (Pubitemid 47236408)
11. Schussheim DH, Skarulis MC, Agarwal SK, Simonds WF, Burns AL, Spiegel AM, Marx SJ (2001) Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab 12: 173-178. (Pubitemid 33713559)
12. Teh BT (1998) Thymic carcinoids in multiple endocrine neoplasia type 1. J Intern Med 243: 501-504. (Pubitemid 28312247)
13. Gould PM, Bonner JA, Sawyer TE, Deschamps C, Lange CM, Li H (1998) Bronchial carcinoid tumors: importance of prognostic factors that influence patterns of recurrence and overall survival. Radiology 208: 181-185. 14. Burgess JR, Greenaway TM, Parameswaran V, Challis DR, David R, Shepherd JJ (1998) Enteropancreatic malignancy associated with multiple endocrine neoplasia type 1 : risk factors and pathogenesis. Cancer 83: 4287-4434 (Pubitemid 28323328)
14. Norton JA, Melcher ML, Gibril F, Jensen RT (2004) Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery 136: 1267-1274. (Pubitemid 39647544)
15. Gibril F, Chen Y-J, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, Reynolds JC, Louie A, Entsuah LK, Huang K, Asgharian B, Jensen RT. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1 (2003) J Clin Endocrinol Metab 88: 1066-1081. (Pubitemid 36337758)
16. Ferolla P, Falchetti A, Filosso P, Tomassetti P, Tamburrano G, Avenia N, Daddi G, Puma F, Ribacchi R, Santeusanio F, Angeletti G, Brandi ML (2005) Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab 90: 2603-2609. (Pubitemid 40686297)
17. Morgello S, Schwartz E, Horwith M, King ME, Gorden P, Alonso DR (1988) Ectopic insulin production by a primary ovarian carcinoid. Cancer 61: 800-805. (Pubitemid 18037934)
18. Sakurai A, Shirahama S, Fujimori M, Katai M, Itakura Y, Kobayashi S, Amano J, Fukushima Y, Hashizume K (1998) Novel MEN1 gene mutations in familial multiple endocrine neoplasia type 1. J Hum Genet 43: 199-201. (Pubitemid 128508733)
19. Tham E, Grandell U, Lindgren E, Toss G, Skogseid B, Nordenskjöld M (2007) Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. J Clin Endocrinol Metab 92: 3389-3395. (Pubitemid 47435311)
20. Knudson AG Jr (1985) Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45: 1437-1445
21. Kip1 tumor suppressor gene: Still a suspect or proven guilty? Cancer Cell 10: 352-354.
22. Stewart C, Parente F, Piehl F, Farnebo F, Quincey D, Silins G, Bergman L, Carle GF, Lemmens I, Grimmond S, Xian CZ, Khodei S, Teh BT, Lagercrantz J, Siggers P, Calender A, Van de Vem V, Kas K, Weber G, Hayward N, Gaudray P, Larsson C (1998) Characterization of the mouse Men1 gene and its expression during development. Oncogene 17: 2485-2493. (Pubitemid 28544718)
23. Karges W, Maier S, Wissmann A, Dralle H, Dosch HM, Boehm BO (1999) Primary structure, gene expression and chromosomal mapping of rodent homologs of the MEN1 tumor suppressor gene. Biochim Biophys Acta 1446: 286-294. (Pubitemid 29401901)
24. Ikeo Y, Sakurai A, Hashizume K (1999) Characterization of the MEN1 gene product, menin, by site-specific polyclonal antibodies. Jpn J Cancer Res 90: 1088-1095.
25. Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK, Besser GM, O'Riordan JL (1989) Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 321: 218-224. (Pubitemid 19187162)
26. Weil RJ, Vortmeyer AO, Huang S, Boni R, Lubensky IA, Pack S, Marx SJ, Zhuang Z, Oldfield EH (1998) 11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1. Clin Cancer Res 4: 1673-1678. (Pubitemid 28304728)
27. Lubensky IA, Debelenko LV, Zhuang Z, Emmert-Buck MR, Dong Q, Chandrasekharappa S, Guru SC, Manickam P, Olufemi SE, Marx SJ, Spiegel AM, Collins FS, Liotta LA (1996) Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 56: 5272-5278. (Pubitemid 26383047)
28. Debelenko LV, Zhuang Z, Emmert-Buck MR, Chandrasekharappa SC, Manickam P, Guru SC, Marx SJ, Skarulis MC, Spiegel AM, Collins FS, Jensen RT, Liotta LA, Lubensky IA (1997) Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 57: 2238-2243. (Pubitemid 27247044)
29. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ (1997) Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet 16: 375-378. (Pubitemid 27323304)
30. Farnebo F, Teh BT, Kytölä S, Svensson A, Phelan C, Sandelin K, Thompson NW, Höög A, Weber G, Farnebo LO, Larsson C (1998) Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 83: 2627-2630. (Pubitemid 28493751)
31. Carling T, Correa P, Hessman O, Hedberg J, Skogseid B, Lindberg D, Rastad J, Westin G, Akerström G (1998) Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab 83: 2960-2963. (Pubitemid 28493806)
32. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, Park WS, Agarwal SK, Debelenko LV, Kester M, Guru SC, Manickam P, Olufemi SE, Yu F, Heppner C, Crabtree JS, Skarulis MC, Venzon DJ, Emmert-Buck MR, Spiegel AM, Chandrasekharappa SC, Collins FS, Burns AL, Marx SJ, Jensen RT, Liotta LA, Lubensky IA (1997) Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57: 4682-4686. (Pubitemid 27468966)
33. Wang EH, Ebrahimi SA, Wu AY, Kashefi C, Passaro E Jr, Sawicki MP (1998) Mutation of the MENIN gene in sporadic pancreatic endocrine tumors. Cancer Res 58: 4417-4420. (Pubitemid 28450045)
34. Görtz B, Roth J, Krähenmann A, de Krijger RR, Muletta-Feurer S, Rütimann K, Saremaslani P, Speel EJ, Heitz PU, Komminoth P (1999) Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Am J Pathol 154: 429-436. (Pubitemid 29094093)
35. Teh BT, Zedenius J, Kytölä S, Skogseid B, Trotter J, Choplin H, Twigg S, Farnebo F, Giraud S, Cameron D, Robinson B, Calender A, Larsson C, Salmela P (1998) Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg 228: 99-105. (Pubitemid 30190322)
36. Öberg K. Carcinoid tumors, the carcinoid syndrome, and related disorders. In Williams Textbook of Endocrinology, edn 11, ch. 44, pp. 1821-1840. Eds. HM Kronenberg, S Melmed, KS Polonsky, PR Larsen. Philadelphia: Saunders, 2006.
37. Romero FR, Rais-Bahrami S, Permpongkosol S, Fine SW, Kohanim S, Jarrett TW (2006) Primary carcinoid tumors of the kidney. J Urol 176: 2359-2366.
38. Murali R, Kneale K, Lalak N, Delprado W (2006) Carcinoid tumors of the urinary tract and prostate. Arch Pathol Lab Med 130: 1693-1706. (Pubitemid 44683800)
39. Canavese G, Azzoni C, Pizzi S, Corleto VD, Pasquali C, Davoli C, Crafa P, Delle Fave G, Bordi C (2001) p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior. Hum Pathol 32: 1094-1101. (Pubitemid 33015670)